Whistleblower law firm Phillips & Cohen selected for 2009 "Hot List" of plaintiffs' law firms

Oct. 5, 2009, WASHINGTON, DC -- Phillips & Cohen LLP, the nation's most successful whistleblower law firm, was named to National Law Journal's "Plaintiffs' Hot List" for 2009 because of its success with qui tam cases on behalf of whistleblowers.

Only 15 law firms were selected for the prestigious national list. It is the third time in six years Phillips & Cohen has been named to the annual list for its work representing whistleblowers in qui tam lawsuits brought under the False Claims Act.

The National Law Journal selected law firms for their "exemplary, cutting edge work," "impressive track record within the previous three to five years" and "wins that could effect significant social change or civil rights gains."

"We looked for firms that struck us as representing the bar's best qualities and that demonstrated unusual flair and creativity," the National Law Journal said.

The publication highlighted three of Phillips & Cohen record-setting cases from the past year:
Northrop Grumman paid $325 million to settle a qui tam case alleging the company sold faulty electronic components to the government for military and intelligence-gathering satellites. It was the largest settlement ever paid by a defense contractor in a qui tam whistleblower case and the second largest settlement ever paid involving defense contractor fraud.

Quest Diagnostics paid $302 million to settle a qui tam lawsuit alleging a subsidiary manufactured and sold faulty medical tests that put the health of dialysis patients at risk. It was the largest settlement ever paid by a medical lab company for a faulty product.

Cephalon paid a total of $425 million to settle a qui tam lawsuit brought by Phillips & Cohen as well as three other whistleblower cases and a criminal charge involving its off-label marketing practices of Actiq and other prescription drugs. It was the first case to calculate civil damages based primarily on the extent to which the defendant marketed its drugs for off-label indications for which there were no credible published scientific research supporting the drugs' safety or effectiveness.

Phillips & Cohen's largest qui tam settlement came after the deadline for the "Hot List" nominations: Pfizer Inc. paid $1.8 billion to settle the off-label marketing case involving the painkiller Bextra and a related criminal charge as part of a record-breaking $2.3 billion settlement announced on Sept. 2.

Phillips & Cohen represents whistleblowers across the nation in cases involving fraud against the government, including tax fraud and securities laws violations. It was named to the "Plaintiffs' Hot List" in 2004 and 2007 as well as 2009. For more information about Phillips & Cohen's record, see P&C's Successful Whistleblower Cases.